Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-23

FDA Approved: BUPRENORPHINE — Original Application (INGENUS PHARMACEUTICALS, LLC)

View source ↗

Summary

FDA approved a generic buprenorphine product from Ingenus Pharmaceuticals under the original ANDA application (ANDA210272).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

ORIG AP for BUPRENORPHINE (BUPRENORPHINE)